Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Metabolic Costs of Walking Post Stroke

22 de octubre de 2018 actualizado por: University of Texas Southwestern Medical Center

The Impact of Gait Training on the Metabolic Costs of Walking and Cardiorespiratory Capacity in Persons Post Stroke

This will be a randomized, matched-group study to compare the cardiopulmonary / metabolic benefits for persons post stroke that learn to walk utilizing early treadmill training post-acute stroke to persons post stroke that learn to walk utilizing non-treadmill based gait training during the same time period. Participants (n=30) will be adults who have completed acute rehabilitation following a stroke. Random assignment will be to either the ESTT or traditional gait training protocol during the outpatient rehabilitation phase.

  1. Group A: Traditional outpatient therapy (n = 15)
  2. Group B: Treadmill training (ESTT) outpatient therapy (n = 15)

Descripción general del estudio

Estado

Terminado

Descripción detallada

At the time of enrollment, participants will be randomly assigned to one of the two groups depending on the severity of impairment in the hemiparetic lower extremity. Groups will be matched based on high functioning vs. low functioning (STREAM scores). Group assignment will be done by random drawing from concealed envelopes with red or blue chips for assignment to ESTT or non-treadmill based outpatient therapy services. For the next participant who is screened with a similar STREAM impairment level, he/she will be placed in the alternate group to match the group assignments. Enrollment will proceed in this fashion. All outpatient therapy services will be provided at the UT Southwestern School of Health Professions School of Physical Therapy Gait Disorders Clinic (UTSW GDC). The groups will be as follows:

  1. Group A: Traditional outpatient therapy (n = 15)
  2. Group B: Treadmill (ESTT) outpatient therapy (n = 15) Therapy for the purposes of the study will be discontinued after a maximum of 24 training sessions or 8 weeks. It is anticipated, based on the research concerning AFO use in persons with stroke, that all participants will require an AFO for safe gait training in the outpatient setting.

Traditional outpatient therapy: For persons in Group A, gait training will consist of 30 minutes of walking training. The program may include a variety of interventions that are commonly done to rehabilitate gait after stroke (excluding treadmill training). Walking may include the use of various assistive devices such as rolling walkers, gait trainers, canes and crutches. Other tools that may be utilized include visual cues (tape, lasers) and auditory cues (metronome). Other activities such as single limb stance and stair climbing may be included to facilitate limb stability. Functional electrical stimulation (FES) may be used to facilitate muscle activation in the hemiparetic lower extremity during gait training for all participants. Stimulation may be applied to muscles of the upper and/or lower leg gait training. Use of electrical stimulation will be documented, including all parameters (make and model of unit, rate of stimulation [pulses per second], waveform, and duration of use). Appropriate exercises from a bank of exercises will be selected for each participant. The bank of exercises will include: standing heel cord stretches, single leg stance, sit to stand, timed standing, marching in place, tap ups, step ups, step throughs, standing ball roll, stair climbing, standing Theraband exercises, wall squats. They will be advised to complete the exercises daily (5 days/week total) for a total of 30 minutes per day. In addition, they will be instructed to wear the AFO for all upright mobility tasks, in combination with the prescribed assistive device.

Treadmill (ESTT) outpatient therapy: For persons in Group B, study-related outpatient gait training will be initiated on the treadmill with partial body weight support. The initial body weight support will be set between 30% and 50% of patient's body weight. During progressive training sessions, the amount of body weight support will attempt to be reduced and the researcher will assess the response to the increased body weight on the gait pattern. The initial speed of the treadmill will be 0.7 mph (minimum initial speed) and will be increased progressively as tolerated until a speed of 1.8 mph is reached. Subject tolerance to the intervention will be monitored closely. Gait training on the treadmill will be scheduled in 30-minute sessions. The subjects will be allowed to take rest breaks as needed during the treadmill training.

During gait training on the treadmill, ankle control will be facilitated by means of an ankle foot orthosis (AFO) with a double adjustable joint. For over ground gait, participants will also use an AFO with a double adjustable joint Functional electrical stimulation (FES) may be used to facilitate muscle activation in the hemiparetic lower extremity during gait training for all participants. Over ground gait will not be initiated until the subject is able to walk on the treadmill with no more than 10% body weight support and with no more than minimal assist to advance the hemiparetic leg at a speed of 0.8 mph or greater for at least 3 minutes for two consecutive bouts. (Subjects can also have assistance with weight shift.) Once over ground gait is initiated, either bilateral or unilateral support will be used, depending on upper extremity control and general upright stability. If the quality of the gait deteriorates significantly from the gait observed on the treadmill, over ground gait will be halted for that session. Treadmill training will continue to progress to over ground gait. Once over ground gait training is initiated, 20 minutes of the 30 total therapy minutes will be spent on treadmill training and 10 minutes will be spent on over ground gait training. Treadmill training will continue until subjects are able to walk 10 minutes without resting with no body weight support, but with vest on for safety, without upper extremity support without assist for weight shift or lower extremity control at a speed of 1.8 mph. If this is prior to the conclusion of study-related therapy, the entire 30 minute session will be spent practicing over ground gait.

Appropriate exercises from a bank of exercises will be selected for each participant. The bank of exercises will include: standing heel cord stretches, single leg stance, sit to stand, timed standing, marching in place, tap ups, step ups, step throughs, standing ball roll, stair climbing, standing Theraband exercises, wall squats. They will be advised to complete the exercises daily (5 days/week total) for a total of 30 minutes per day. In addition, they will be instructed to wear the AFO for all upright mobility tasks, in combination with the prescribed assistive device.

The Step Program: To introduce this component of the study, the participant and caregiver/support person will be given a 15-minute presentation entitled Step it Up. This program was developed by the research team and it addresses the critical need and benefits of exercise for persons post stroke, methods of safe exercise monitoring and information on progression of exercise intensity and duration to improve cardiorespiratory function. The presentation will include an explanation of the Borg Rate of Perceived Exertion (RPE, 6-20 scale) and directions on how to utilize a pedometer for daily walking measurement. Following the presentation, participants will meet with an investigator and demonstrate competency with the application of the pedometer and utilization of the RPE scale. Each participant will be provided written material that covers the salient points of the presentation. They will also receive a notebook that has the instructions along with 16 weekly logs for recording walking data. The training should take approximately 30 minutes and will take place following the final gait treatment.

The walking program will continue until T4 and T4a. Each participant will be scheduled for this testing within 10 calendar days of the 24-week anniversary of the commencement of outpatient therapy. At this testing time (T4 & T4a) all outcome measures will be repeated. The final testing time (T5 and T5 a) will be completed within 10 calendar days of 288-day anniversary of commencement of outpatient physical therapy. All outcome measures will be repeated at this testing time. This will be the termination point of the study.

Tipo de estudio

Intervencionista

Inscripción (Actual)

16

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Texas
      • Dallas, Texas, Estados Unidos, 75390
        • UT Southwestern School of Health Professions

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 80 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • confirmed diagnosis of recent cerebrovascular accident (CVA) (less than 6 weeks post at the time of admission to inpatient rehabilitation)
  • able to give informed consent independently or have family member or other authorized surrogate available to give consent
  • first time stroke OR complete gait recovery from prior stroke
  • sufficient support at home to participate in home-based fitness training program
  • transportation to University of Texas Southwestern Medical Center Gait Disorders Clinic (UTSW GDC) for therapy and testing
  • ability to follow one-part commands

Exclusion Criteria:

  • non-ambulatory before onset of stroke (at time of admission to inpatient rehabilitation)
  • bilateral stroke
  • presence of severe cardiac problems (heart failure [New York Heart Association > Class 2], unstable or exercise-induced angina)
  • other co-morbidities which could affect gait training (i.e. amputation, spinal cord injury, traumatic brain injury, etc.)
  • recent myocardial infarct (within 4 weeks of date of inpatient rehabilitation admission)
  • any uncontrolled health condition for which exercise is contraindicated
  • severe lower extremity joint disease/pathology that would interfere with gait training
  • subjects -with body mass index (BMI) greater than 40
  • significant cognitive impairment (less than 2 on the Functional Independence Measure [FIM] cognitive sub-scale)
  • age greater than 80 years or less than 18 years
  • able to complete 5 or more full heel raises with the affected ankle in standing with the knee extended with no more than one or two fingers on support surface for balance

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Traditional outpatient
Traditional outpatient physical therapy
Traditional physical therapy includes standard of care for gait recovery after stroke such as pre-gait activities, standing balance activities, strengthening, walking with assistive devices.
Experimental: ESTT outpatient
ESTT (early standardized task-specific training) in outpatient rehabilitation
ESTT is early-standardized task-specific training is a treadmill and over ground gait protocol for gait recovery after stroke

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Maximum Exercise Tolerance Testing
Periodo de tiempo: Change in exercise tolerance from enrollment to 9 weeks later and 25 weeks later
Exercise tests will be performed with a treadmill with a static/dynamic body weight system. Measurements will be conducted with open circuit spirometry. Heart rate will be continuously monitored by electrocardiogram. Blood pressure will be monitored every 2 minutes. Participants will be allowed a 3-minute warm-up. Following the warm-up, participants will be allowed up to 10 minutes to rest or until they recovery to baseline heart rate, respiration rate and blood pressure.
Change in exercise tolerance from enrollment to 9 weeks later and 25 weeks later
Change in 6-Minute Walk Test Distance
Periodo de tiempo: At enrollment and week 25.
Each subject will be asked to complete a 6-Minute Walk test. They will be advised to walk at a pace they think they can maintain for the entire time. Resting is permitted provided they are not required to sit. Participants will not be given any verbal encouragement during the test. A stop watch will be used to time the test and the distance will be measured with a calibrated measuring wheel along a 150 foot corridor. Heart rate will be monitored during the test by means of a Polar chest strap and values will be recorded at each minute of the test. Perceived rate of exertion using the Borg scale of 6-20 will be recorded at rest and each minute of the test.34 Blood pressure using an automated arm cuff will be recorded before and after the test.
At enrollment and week 25.

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Temporal Spatial Gait Analysis
Periodo de tiempo: At enrollment, week 9, week 17 and week 25.
Testing will be completed using a 14'x4', 16-level pressure sensing Zeno Walkway. This system utilizes a computerized gait system for data collection. Gait parameters that will be collected include center of pressure, center of mass, step/stride length, velocity, toe in/out, cadence, and left/right lower extremity ratios. Participants will be asked to walk at self-selected and safe fast walking paces for repeated straight direction walking trials to collect an average of 100 feet of straight distance. This testing will be done at T1, T2, T3 and T4. This test takes 15 minutes to complete.
At enrollment, week 9, week 17 and week 25.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Karen J McCain, DPT, UT Southwestern Medical Center

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de marzo de 2014

Finalización primaria (Actual)

1 de enero de 2017

Finalización del estudio (Actual)

1 de enero de 2017

Fechas de registro del estudio

Enviado por primera vez

28 de marzo de 2014

Primero enviado que cumplió con los criterios de control de calidad

4 de abril de 2014

Publicado por primera vez (Estimar)

9 de abril de 2014

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

1 de marzo de 2019

Última actualización enviada que cumplió con los criterios de control de calidad

22 de octubre de 2018

Última verificación

1 de octubre de 2018

Más información

Términos relacionados con este estudio

Palabras clave

Otros números de identificación del estudio

  • AHA CV study
  • AHA Award #14CRP18500016 (Otro número de subvención/financiamiento: American Heart Association)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir